Brokerages Set Myriad Genetics, Inc. (NASDAQ:MYGN) Target Price at $15.79
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) has earned an average rating of “Hold” from the seventeen research firms that are currently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and four have issued a buy recommendation on the company. […]
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) has earned an average rating of “Hold” from the seventeen research firms that are currently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and four have issued a buy recommendation on the company. […]
